Latest news with #JamiesonWellness'
Yahoo
27-05-2025
- Business
- Yahoo
Jamieson Wellness Inc. Announces Voting Results from 2025 Annual Meeting of Shareholders
TORONTO, May 27, 2025 (GLOBE NEWSWIRE) -- Jamieson Wellness Inc. ('Jamieson Wellness' or the 'Company') (TSX: JWEL) announced today that each of the nominee directors listed in the management information circular of the Company dated March 10, 2025 was elected as a director of the Company (a 'Director') at the annual meeting (the 'Meeting') of the holders of common shares of the Company (the 'Common Shares') held today. The number of Common Shares voted in person or by proxy for the election of each Director or withheld was as indicated below: Name of Nominee Votes For % Votes Withheld % Heather Allen 33,842,993 99.86% 46,448 0.14% Dr. Louis Aronne 33,863,450 99.92% 25,991 0.08% Tania Clarke 33,885,796 99.99% 3,645 0.01% Diane Nyisztor 33,885,001 99.99% 4,440 0.01% Michael Pilato 33,858,957 99.91% 30,484 0.09% Timothy Penner 33,873,816 99.95% 15,625 0.05% François Vimard 33,883,746 99.98% 5,695 0.02% Mei Ye 33,882,842 99.98% 6,599 0.02% Final results on all matters voted at the Meeting will be filed with the Canadian securities regulatory authorities and will be available on the Company's SEDAR+ profile at About Jamieson Wellness Jamieson Wellness is dedicated to Inspiring Better Lives Every Day with its portfolio of innovative natural health brands. Established in 1922, the Jamieson brand is Canada's #1 vitamins, minerals and supplements ('VMS') brand. The Company's youtheory brand, acquired in 2022, is an established and growing lifestyle brand in the U.S. Combined, these global brands are available in more than 50 countries worldwide. The Company also offers a variety of innovative VMS products as well as sports nutrition products to consumers in Canada with its Progressive, Smart Solutions, Iron Vegan and Precision brands. The Company is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. For more information please visit Jamieson Wellness' head office is located at 1 Adelaide Street East Suite 2200, Toronto, Ontario, Canada. Investor and Media Contact:Ruth WinkerJamieson Wellness416-960-0052rwinker@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
08-05-2025
- Business
- Business Wire
Jamieson Wellness Inc. Reports First Quarter 2025 Results
TORONTO--(BUSINESS WIRE)--Jamieson Wellness Inc. ('Jamieson Wellness' or the 'Company') (TSX: JWEL) today reported its first quarter results for the period ended March 31, 2025. All amounts are expressed in Canadian dollars. Certain metrics, including those expressed on an adjusted basis, are non-IFRS and other financial measures. See 'Non-IFRS and Other Financial Measures' below. 'Our team delivered solid results in Q1 that continued to demonstrate the power of our strategy in action,' said Mike Pilato, President and CEO of Jamieson Wellness. 'Consolidated revenue growth in the quarter was 14%, and branded revenue growth of 13.9% exceeded our expectations. We also grew Adjusted EBITDA ahead of revenue, reflecting both sustained global demand for our products and our team's precise execution in meeting that opportunity. "Our China business grew over 50% in Q1 as we capitalized on our strategic investments and tailored approach to this key region. In the U.S, we are on track to meet our growth expectations as we are actively expanding the youtheory brand with our new e-commerce partner. Our strategic initiatives in Canada and International markets reflected both category strength and our continued ability to outpace market growth. "2025 is off to a great start. We're executing on our innovation roadmap, expanding channel reach, and enhancing operational efficiency to maintain this momentum. This focused strategy will continue to drive revenue, EBITDA, and cash flow growth in the coming year. We're grateful for our team's unwavering dedication and the loyalty of our customers and consumers as we continue to deliver innovative natural health solutions and build on our foundation of profitable growth." First Quarter Highlights Strong consumer consumption in Canada led by continued growth in club and e-commerce channels Revenue growth in China exceeded expectations, driven by strengthening brand awareness, focus on social commerce, retail, and cross-border strategies Elevated consumer consumption of the youtheory brand across all channels, impacted by timing of innovations in the same quarter prior year Immunity and women's health focused campaigns drove demand in the Middle East and Asia Published second annual sustainability impact report, detailing progress towards the Company's 2030 and 2050 sustainability goals First Quarter Financial Results Consolidated Summary All comparisons are with the first quarter of 2024 Consolidated revenue increased 14.0% to $146.0 million, driven by 13.9% growth in Jamieson Brands and 14.9% growth in Strategic Partners Gross profit increased by $12.4 million to $55.2 million; normalized gross profit increased by $10.4 million largely driven by higher revenues and increased margins Gross profit margin 3 increased by 440 basis points; normalized gross profit margin increased 270 basis points due to volume driven efficiencies and favourable channel mix EBITDA 1 increased by $0.6 million to $7.8 million, mainly driven by higher revenues and gross profit; Adjusted EBITDA 1 increased by $3.0 million or 18.4% to $19.1 million, reflecting the impact of higher sales volumes and gross profit margins, partially offset by investments in SG&A Net loss was $2.5 million; Adjusted net earnings 1 was $5.9 million, or $2.0 million higher, reflecting higher normalized earnings from operations Diluted earnings per share was ($0.06); Adjusted diluted earnings per share 2 was $0.14 Summary of Segment Results All comparisons are with the first quarter of 2024 Jamieson Brands Revenue increased 13.9% or $16.0 million to $131.4 million Canada revenue increased by 14.3% to $69.5 million, driven by continued strong consumer consumption and pricing while lapping lower shipments prior year due to the labour disruption China revenue increased 52.1% to $28.5 million, driven by strengthening of brand awareness and growth in social e-commerce that continues to outpace the market youtheory revenue declined by 13.0% to $26.5 million as expected. Strong consumption driving shipment growth of 16.5% in traditional channels in the quarter was offset by the impact of lapping innovation pipefill in Q1 2024. Q1 2025 revenue growth increased by 19.3% vs Q1 2023. International revenue increased by 28.8% to $6.9 million, driven by growth in key markets while lapping lower shipments prior year due to the labour disruption Gross profit increased by $12.7 million to $53.8 million; normalized gross profit increased by $10.4 million mainly due to higher revenues and increased margins Gross profit margin 3 increased by 520 basis points to 40.9%; normalized gross profit margin increased by 320 basis points to 41.7%, mainly due to volume driven efficiencies and favourable channel mix Adjusted EBITDA 1 increased by $3.1 million to $18.3 million, driven by higher gross profit partially offset by increased investments in SG&A to support growth and brand awareness in China; Adjusted EBITDA margin 2 was 13.9%, an increase of 80 basis points mainly due to higher normalized gross profit Strategic Partners Revenue increased 14.9% or $1.9 million to $14.6 million, driven by shipments of new customer contracts awarded in the fourth quarter of the prior year and timing of customer orders Gross profit was $1.4 million, a decrease of $0.2 million; gross profit margin 3 was 9.8%, a decrease of 320 basis points; normalized gross profit margin decreased by 160 basis points to 11.4% driven mainly by customer mix Adjusted EBITDA 1 was $0.8 million, a decrease of $0.2 million; Adjusted EBITDA margin 2 was 5.4%, a decrease of 230 basis points Balance Sheet and Cash Flow from Operations All comparisons are with the first quarter of 2024 As at March 31, 2025, the Company had approximately $246.1 million in cash and available revolving and swingline facilities and net debt 1 of $253.9 million The Company generated $31.6 million in cash from operations compared to $7.3 million used in Q1 2024 Cash from operating activities before working capital considerations of $4.7 million was consistent with prior year Cash generated from working capital increased by $38.8 million driven by lower accounts receivable due to the timing of customer collections During the period ended March 31, 2025, the Company purchased for cancellation 348,160 Common Shares under its NCIB program for an aggregate consideration of $10.0 million 1 This is a non-IFRS financial measure. See the 'Non-IFRS and Other Financial Measures' section of this press release for more information on each non-IFRS financial measure. 2 This is a non-IFRS ratio. See the 'Non-IFRS and Other Financial Measures' section of this press release for more information on each non-IFRS ratio. 3 This is a supplementary financial measure. See the 'Non-IFRS and Other Financial Measures' section of this press release for more information on each supplementary financial measure. Expand Maintaining Fiscal 2025 Outlook The Company is maintaining its outlook for the 2025 fiscal year and continues to anticipate the following: Revenue to range between $800.0 to $840.0 million (+9.0% to +14.5% growth) Adjusted EBITDA to range from $157.0 to $163.0 million (+11.0% to +15.5% growth) Adjusted diluted earnings per share to range from $1.82 to $1.93 (+13.0% to +20.0% growth) Based on the currently announced tariff framework, which the Company recognizes is constantly evolving, no material impact is expected in 2025. For additional details on the Company's fiscal 2025 outlook, including guidance for the second quarter of 2025, refer to the 'Outlook' section in the management's discussion and analysis of financial condition and results of operations ('MD&A') for the three months ended March 31, 2025. Declaration of First Quarter Dividend The board of directors of the Company declared a cash dividend for the first quarter of 2025: $0.21 per common share, or approximately $8.8 million in the aggregate Paid on June 13, 2025 to all common shareholders of record at the close of business on May 30, 2025 The Company has designated this dividend as an 'eligible dividend' for the purposes of the Income Tax Act (Canada) Consolidated Financial Statements and Management's Discussion and Analysis The Company's unaudited condensed consolidated interim financial statements and accompanying notes as at and for the three months ended March 31, 2025 and related MD&A are available under the Company's profile on SEDAR+ at and on the Investor Relations section of the Company's website at Conference Call Management will host a conference call to discuss the Company's first quarter 2025 results at 5:00 p.m. ET today, May 8, 2025. To access: By phone: 1-844-763-8274 from Canada and the U.S. or 1-647-484-8814 from international locations Online: or About Jamieson Wellness Jamieson Wellness is dedicated to Inspiring Better Lives Every Day with its portfolio of innovative natural health brands. Established in 1922, the Jamieson brand is Canada's #1 vitamins, minerals and supplements ('VMS') brand. The Company's youtheory brand, acquired in 2022, is an established and growing lifestyle brand in the U.S. Combined, these global brands are available in more than 50 countries worldwide. The Company also offers a variety of innovative VMS products as well as sports nutrition products to consumers in Canada with its Progressive, Smart Solutions, Iron Vegan and Precision brands. The Company is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. For more information please visit Jamieson Wellness' head office is located at 1 Adelaide Street East Suite 2200, Toronto, Ontario, Canada. Forward-Looking Information This press release may contain forward-looking information within the meaning of applicable securities legislation. Such information includes, but is not limited to, statements related to the Company's anticipated results and its outlook for its 2024 revenue, Adjusted EBITDA and Adjusted diluted earnings per share. Words such as 'expect', 'anticipate', 'intend', 'may', 'will', 'estimate' and variations of such words and similar expressions are intended to identify such forward-looking information. This information reflects the Company's current expectations regarding future events. Forward-looking information is based on a number of assumptions and is subject to a number of risks and uncertainties, many of which are beyond the Company's control that could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking information. Such risks and uncertainties include, but are not limited to, the factors discussed under 'Risk Factors' in the Company's Annual Information Form dated March 31, 2025 and under the 'Risk Factors' section in the MD&A filed today, May 8, 2025. This information is based on the Company's reasonable assumptions and beliefs in light of the information currently available to it and the statements are made as of the date of this press release. The Company does not undertake any obligation to update such forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law or regulatory authority. The Company cautions that the list of risk factors and uncertainties is not exhaustive and other factors could also adversely affect the Company's results. Readers are urged to consider the risks, uncertainties and assumptions associated with these statements carefully in evaluating the forward-looking information and are cautioned not to place undue reliance on such information. See 'Forward-looking Information' and 'Risk Factors' within the MD&A for a discussion of the uncertainties, risks and assumptions associated with these statements. Jamieson Wellness Inc. Consolidated Statements of Financial Position In thousands of Canadian dollars December 31, 2024 Assets Current assets Cash 41,113 44,787 Accounts receivable 128,113 228,031 Inventories 177,947 154,658 Derivatives 1,441 2,661 Prepaid expenses and other current assets 8,757 6,803 Income taxes recoverable 4,037 - 361,408 436,940 Non-current assets Property, plant and equipment 102,294 103,591 Goodwill 287,454 287,503 Intangible assets 375,684 377,214 Deferred income tax 3,855 3,545 Total assets 1,130,695 1,208,793 Liabilities Current liabilities Accounts payable and accrued liabilities 97,284 137,653 Income taxes payable 990 4,373 Derivatives 2,688 2,982 Current portion of other long-term liabilities 27,740 27,673 128,702 172,681 Long-term liabilities Long-term debt 295,000 308,285 Post-retirement benefits 1,238 1,209 Deferred income tax 62,601 64,467 Redeemable preferred shares 100,410 98,138 Other long-term liabilities 14,334 15,633 Total liabilities 602,285 660,413 Equity Share capital 325,426 326,219 Warrants 14,705 14,705 Contributed surplus 24,029 23,835 Retained earnings 80,521 99,109 Accumulated other comprehensive income 40,576 41,313 Total shareholders' equity 485,257 505,181 Non-controlling interests 43,153 43,199 Total equity 528,410 548,380 Total liabilities and equity 1,130,695 1,208,793 Expand Non-IFRS and Other Financial Measures This press release makes reference to certain financial measures, including non-IFRS financial measures that are historical, non-IFRS measures that are forward-looking, non-GAAP ratios and supplementary financial measures. Management uses these financial measures for purposes of comparison to prior periods and development of future projections and earnings growth prospects. This information is also used by management to measure the profitability of ongoing operations and in analyzing the Company's business performance and trends. These measures are not recognized measures under IFRS, do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by providing further understanding of the Company's results of operations from management's perspective. Accordingly, they should not be considered in isolation nor as a substitute for analysis of the Company's financial information reported under IFRS. The Company uses the following non-IFRS financial measures: 'EBITDA', 'Adjusted EBITDA' and 'Adjusted net earnings', the most directly comparable financial measure for each that is disclosed in its financial statements being net earnings, 'normalized gross profit', 'normalized SG&A', 'normalized earnings from operations', 'cash from operating activities before working capital considerations' and 'net debt', the most directly comparable financial measures for each that is disclosed in its financial statements being gross profit, SG&A, earnings from operations, cash flows from operating activities, and long-term debt, respectively, the following non-IFRS ratios: 'Adjusted EBITDA margin', 'Adjusted diluted earnings per share', 'normalized gross profit margin', 'normalized operating margin', and the following supplementary financial measures: 'gross profit margin' and 'operating margin' to provide supplemental measures of the Company's operating performance and thus highlight trends in the Company's core business that may not otherwise be apparent when relying solely on IFRS financial measures. Management also uses non-IFRS and supplementary financial measures in order to prepare annual operating budgets and to determine components of management compensation. For an explanation of the composition of each such measure and the usefulness and additional uses of each by management, see the 'How we Assess the Performance of our Business' section of the MD&A, which is incorporated by reference. See below for a quantitative reconciliation of each non-IFRS financial measure to its most directly comparable financial measure disclosed in the Company's financial statements to which the measure relates. The following tables provide a quantitative reconciliation of net earnings to EBITDA, Adjusted EBITDA, and Adjusted net earnings, as well as gross profit to normalized gross profit, SG&A to normalized SG&A, earnings from operations to normalized earnings from operations and net debt, each of which are non-IFRS financial measures (see the 'Non-IFRS and Other Financial Measures' of this press release for further information on each non-IFRS financial measure) for the three months ended March 31, 2025. Reconciliation of Non-IFRS Financial Measures In thousands of Canadian dollars Three months ended March 31 2025 2024 Net loss: (2,514 ) (3,719 ) Add: Recovery of income taxes (1,624 ) (1,124 ) Interest expense and other financing costs 4,908 4,873 Accretion on preferred shares 2,272 2,219 Depreciation of property, plant, and equipment 3,255 3,516 Amortization of intangible assets 1,500 1,384 Earnings before interest, taxes, depreciation, and amortization (EBITDA) 7,797 7,149 Share-based compensation (3) 2,087 1,749 Foreign exchange loss/(gain) 504 (771 ) Labour relations costs (1) - 4,693 IT system implementation (2) 5,535 2,980 Donations (4) 3,118 - Legal and other 25 297 Adjusted EBITDA 19,066 16,097 Recovery of income taxes 1,624 1,124 Interest expense and other financing costs (4,908 ) (4,873 ) Depreciation of property, plant, and equipment (3,255 ) (3,516 ) Amortization of intangible assets (1,500 ) (1,384 ) Share-based compensation (3) (1,965 ) (1,627 ) Tax deduction from vesting of certain share-based awards (689 ) - Tax effect of normalization adjustments (2,425 ) (1,906 ) Adjusted net earnings 5,948 3,915 Three months ended March 31 2025 2024 Gross profit 55,220 42,785 Labour relations costs (1) - 3,253 IT system implementation (2) 1,249 - Normalized gross profit 56,469 46,038 Normalized gross profit margin 38.7 % 36.0 % Selling, general and administrative expenses 49,587 39,558 Donations (4) (3,118 ) - IT system implementation (2) (4,286 ) (2,980 ) Labour relations costs (1) - (1,440 ) Legal and other (25 ) (297 ) Normalized selling, general and administrative expenses 42,158 34,841 Earnings from operations 3,546 1,478 IT system implementation (2) 5,535 2,980 Labour relations costs (1) - 4,693 Donations (4) 3,118 - Legal and other 25 297 Normalized earnings from operations 12,224 9,448 Normalized operating margin 8.4 % 7.4 % Expand (1) Prior year expenses are comprised of third party legal, security fees and unavoidable facility expenditures. All expenses are directly related to the facility closure and collective bargaining process with unionized employees at a manufacturing and warehousing facility in Windsor, Canada. (2) Mainly pertains to development and post implementation start-up costs associated with our IT system implementation to augment our system infrastructure. Unlike other system improvement projects with costs capitalized, due to its cloud-based nature, these system implementation costs are expensed accordingly. (3) Our share-based compensation expense pertains to our long-term incentive plan, with stock options, performance-based share units, time-based restricted share units, and deferred share units expenses, along with associated payroll taxes. (4) Include cash and in-kind donations to support communities adjacent to our Irvine, California facility impacted by the wildfires. Expand
Ottawa Citizen
25-04-2025
- Business
- Ottawa Citizen
Jamieson Wellness Inc. Announces Date of First Quarter 2025 Financial Results and Conference Call
Article content TORONTO — Jamieson Wellness Inc. ('Jamieson Wellness' or the 'Company') (TSX:JWEL) announced today that the Company will release its first quarter 2025 financial results after the market close on Thursday, May 8, 2025. The Company will host a conference call for investors at 5:00 p.m. Eastern Time to discuss the first quarter 2025 results. Article content Article content The call can be accessed live over the telephone by dialing 1-844-763-8274 from Canada and the U.S. or 1-647-484-8814 from international locations. A replay will be available shortly after the call and can be accessed by dialing 1-855-669-9658 from Canada and the U.S. or 1-412-317-0088 from international locations. The passcode for the replay is 5475970 and it will be available until Sunday, June 8, 2025. Article content Article content Interested parties may listen to a simultaneous webcast of the conference call by logging on via the Investor Relations section of the Company's website at or directly at A replay of the webcast will be available for approximately 30 days following the call. Article content About Jamieson Wellness Inc. Article content Jamieson Wellness is dedicated to Inspiring Better Lives Every Day with its portfolio of innovative natural health brands. Established in 1922, the Jamieson brand is Canada's #1 vitamins, minerals and supplements ('VMS') brand. The Company's youtheory brand, acquired in 2022, is an established and growing lifestyle brand in the U.S. Combined, these global brands are available in more than 50 countries worldwide. The Company also offers a variety of innovative VMS products as well as sports nutrition products to consumers in Canada with its Progressive, Smart Solutions, Iron Vegan and Precision brands. The Company is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. For more information please visit Article content Article content Article content Article content Contacts Article content Article content
National Post
24-04-2025
- Business
- National Post
Jamieson Wellness Inc. Announces Date of First Quarter 2025 Financial Results and Conference Call
Article content TORONTO — Jamieson Wellness Inc. ('Jamieson Wellness' or the 'Company') (TSX:JWEL) announced today that the Company will release its first quarter 2025 financial results after the market close on Thursday, May 8, 2025. The Company will host a conference call for investors at 5:00 p.m. Eastern Time to discuss the first quarter 2025 results. Article content Article content The call can be accessed live over the telephone by dialing 1-844-763-8274 from Canada and the U.S. or 1-647-484-8814 from international locations. A replay will be available shortly after the call and can be accessed by dialing 1-855-669-9658 from Canada and the U.S. or 1-412-317-0088 from international locations. The passcode for the replay is 5475970 and it will be available until Sunday, June 8, 2025. Article content Article content Interested parties may listen to a simultaneous webcast of the conference call by logging on via the Investor Relations section of the Company's website at or directly at A replay of the webcast will be available for approximately 30 days following the call. Article content About Jamieson Wellness Inc. Article content Jamieson Wellness is dedicated to Inspiring Better Lives Every Day with its portfolio of innovative natural health brands. Established in 1922, the Jamieson brand is Canada's #1 vitamins, minerals and supplements ('VMS') brand. The Company's youtheory brand, acquired in 2022, is an established and growing lifestyle brand in the U.S. Combined, these global brands are available in more than 50 countries worldwide. The Company also offers a variety of innovative VMS products as well as sports nutrition products to consumers in Canada with its Progressive, Smart Solutions, Iron Vegan and Precision brands. The Company is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. For more information please visit Article content Article content Article content Article content Article content Contacts Article content Article content
Yahoo
03-04-2025
- Business
- Yahoo
Investors in Jamieson Wellness (TSE:JWEL) have seen returns of 19% over the past year
While Jamieson Wellness Inc. (TSE:JWEL) shareholders are probably generally happy, the stock hasn't had particularly good run recently, with the share price falling 17% in the last quarter. But that fact in itself shouldn't obscure what are quite decent returns over the last year. We say this because the stock (which is up 16%) actually surpassed the market return of (15%). With that in mind, it's worth seeing if the company's underlying fundamentals have been the driver of long term performance, or if there are some discrepancies. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time. Jamieson Wellness was able to grow EPS by 9.4% in the last twelve months. This EPS growth is significantly lower than the 16% increase in the share price. This indicates that the market is now more optimistic about the stock. The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers). We consider it positive that insiders have made significant purchases in the last year. Having said that, most people consider earnings and revenue growth trends to be a more meaningful guide to the business. This free interactive report on Jamieson Wellness' earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further. As well as measuring the share price return, investors should also consider the total shareholder return (TSR). The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. We note that for Jamieson Wellness the TSR over the last 1 year was 19%, which is better than the share price return mentioned above. And there's no prize for guessing that the dividend payments largely explain the divergence! It's good to see that Jamieson Wellness has rewarded shareholders with a total shareholder return of 19% in the last twelve months. And that does include the dividend. That gain is better than the annual TSR over five years, which is 3%. Therefore it seems like sentiment around the company has been positive lately. In the best case scenario, this may hint at some real business momentum, implying that now could be a great time to delve deeper. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Take risks, for example - Jamieson Wellness has 2 warning signs (and 1 which is a bit unpleasant) we think you should know about. Jamieson Wellness is not the only stock insiders are buying. So take a peek at this free list of small cap companies at attractive valuations which insiders have been buying. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Canadian exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
